Clinical Trials Logo

Clinical Trial Summary

Obesity and non-alcoholic fatty liver disease (NAFLD) are two related growing epidemics that are becoming pressing public health concerns. High-intensity interval training (HIIT) is a promising cost-effective and time-efficient exercise modality for managing obesity and NAFLD. However, patients with obesity and NAFLD are generally inactive and unfit, and might feel intimidated by the frequency of the prescribed HIIT (conventionally three times weekly). Previous HIIT studies, mostly over 2-4 month periods, showed that the participants could accomplish this exercise frequency under a controlled laboratory environment, but the long-term adherence and sustainability, especially in a field setting, remains uncertain. The situation is more unclear if we also consider those individuals who refused to participate possibly because of their overwhelming perceptions or low self-efficacy toward HIIT. Thus, logically, HIIT at a lower frequency would be practical and more suitable for patients with obesity and NAFLD, but the minimum exercise frequency required to improve health, especially in the long-term, is unknown. This proposed study aims to examine the effectiveness of long-term low-frequency HIIT for improving body adiposity and liver fat in centrally obese adults. The premise of this proposal is supported by recent findings that HIIT performed once every 5-7 days could improve cardiorespiratory fitness, blood pressure, cardiac morphology, metabolic capacity, muscle power, and lean mass. This study will provide evidence for the benefits of long-term low-frequency HIIT with a follow-up period to assess its effectiveness, safety, adherence, and sustainability. We expect this intervention will enhance the practical suitability of HIIT in inactive obese adults and will provide evidence for low-frequency HIIT as a new exercise option in the management of obesity and NAFLD.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03912272
Study type Interventional
Source The University of Hong Kong
Contact JUCHENG YU
Phone 97561053
Email dannyu@connect.hku.hk
Status Recruiting
Phase N/A
Start date January 1, 2019
Completion date January 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT03256526 - 6-week Safety and PD Study in Adults With NAFLD Phase 2
Completed NCT03060694 - Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements
Completed NCT02526732 - Hepatic Inflammation and Physical Performance in Patients With NASH N/A
Recruiting NCT01988441 - The Influence of Autophagy on Fatty Liver
Recruiting NCT01680003 - Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease Phase 2
Completed NCT01712711 - Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease Phase 2
Recruiting NCT00941642 - Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease Phase 4
Active, not recruiting NCT00714129 - De Novo Lipogenesis, Lipid and Carbohydrate Metabolism in Non-alcoholic Fatty Liver Disease N/A
Completed NCT01257685 - Selenoprotein P and Non-alcoholic Fatty Liver Disease N/A
Completed NCT00230087 - Iron Depletion Therapy for Type 2 DM and NAFLD Phase 2
Completed NCT00230113 - Effect of Omega-3 PUFA Supplementation in NAFLD Patients Phase 2
Completed NCT03614039 - Effect of Probiotic and Smectite Gel on NAFLD N/A
Completed NCT02650830 - Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress
Recruiting NCT03613480 - Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD) N/A
Completed NCT03625362 - Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease N/A
Completed NCT01371396 - Effect of Dietary Macronutrient Composition N/A
Completed NCT01431521 - Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008) Phase 1
Recruiting NCT02951546 - Study on Metabolic Flexibility and Gut Microbiota Composition in Obese Subjects With NAFLD, Taking Into Account PNPLA3 and TM6SF2 Polymorphisms. Effects of Nutritional Intervention Combined to Exercise N/A
Completed NCT02974374 - Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects Phase 1
Recruiting NCT02579408 - Quantifying Steatosis in Liver Transplant Donors